Cristian Topriceanu

@CTopriceanu

Innovating for🫀health (#whyCMR, #epi, #Multiomics) | IM resident @MayoMN_IMRES | post-doc @brighamwomens | MBBS PhD @ucl | biomed engineering @imperialcollege

United States linkedin.com/in/constantin-… Joined December 2020

312 Following 296 Followers 214 Posts

Latest posts 5

Pinned post

Cristian Topriceanu @CTopriceanu Mar 30, 2025

I am truly humbled to receive the William W. Parmley Award. This acknowledgment reinforces my commitment to excellence in #Cardiology, and I am eager to continue contributing meaningfully to the @ACCinTouch/ @JACCJournals community.

Special thanks to my mentor @gabycaptur!

@MRCLHA @UCL_ICS

JACC Journals @JACCJournals Mar 30, 2025

#JACC has honored 5️⃣ primary authors with the William W. Parmley Young Author Achievement Award, recognizing their exceptional research papers published in the journal.

📎: acc.org/About-ACC/Pres…

#ACC25 #TheFaceOfCardiology @CHRLee1212 @safchat @CTopriceanu

View quoted post on X

Cristian Topriceanu @CTopriceanu Mar 30

#ACC26 New Orleans — what a conference. 🎉

The science, the debates, the energy. Unmatched.

@JACCJournals @ACCinTouch

Sara Ersözlü, MD, CCK, FACC Verified account @ErsozluSara Mar 30

Cardiac imagers coming together at the @JACCJournals reception at #ACC26, Multimodality #whyCMR #whyCCT #EchoFirst #whyPET, subspecialty imaging societies @SCMRorg @Heart_SCCT @ASE360, multinational and transcontinental. @ACCinTouch

View quoted post on X

Cristian Topriceanu @CTopriceanu Mar 30

🚨 #ACC26 | SMART-DECISION

In 2,540 stable post-#MI pts (LVEF ≥40%, no #HF) on β-blockers ≥1yr, discontinuation vs continuation: 7.2% vs 9.0% composite (#death/#MI/#HF hosp); HR 0.80 (95% CI 0.57–1.13) — noninferior (p=0.001).

@JACCJournals @ACCinTouch

Cristian Topriceanu @CTopriceanu Mar 30

#ACC26 | ESSENCE-CTA: Olezarsen drove TG ↓64%, remnant cholesterol ↓72%, ApoB ↓16% vs placebo — but noncalcified coronary plaque changed –5.35% vs –3.91% (placebo-adjusted diff +2.98%, p=0.36).

No difference in any plaque subtype at 12 months. ❌

@JACCJournals @ACCinTouch

Cristian Topriceanu @CTopriceanu Mar 29

#ACC26 PROTECT H2H: First head-to-head RCT of embolic protection in #TAVR (n=522).

30-day composite of all-cause #death, #stroke and acute kidney failure: 4.9% (Emboliner) vs. 5.0% (Sentinel).
Stroke: 2.0% vs. 2.1%. Particle capture: 1,575 vs. 801. Placement success: 96% vs. 87%.

@JACCJournals @ACCinTouch